Kit for indentifying prostatic intraepithelial neoplasia (PIN)

Details Kit for indentifying prostatic intraepithelial neoplasia (PIN) Kit for indentifying prostatic intraepithelial neoplasia (PIN)

1997-11-07

2000-04-25

Seaman, D. Margaret

Chemistry: analytical and immunological testing

Cancer

G03G 1504

Patent

active

060543205

ABSTRACT:
The invention relates to methods for identifying prostatic intraepithelial neoplasia, methods for determining metastatic potential of tumors, and to methods and compositions for inhibiting or preventing metastasis of cancers. In one aspect, the invention provides a method to determine metastatic potential of tumors, particularly prostatic tumors. In another aspect, the invention provides a method of identifying prostate cancer associated conditions, particularly prostatic intraepithelial neoplasia. In these regards, the invention relates to determining protein or mRNA of effectors of arachidonic acid release, particularly uteroglobin protein or mRNA, to identify intermediate conditions such as PIN or to gauge metastatic potential of prostatic tumors. The invention also relates to methods and compositions that prevent or inhibit metastasis of cancers. In this regard, the invention particularly relates to methods and compositions that inhibit arachidonic acid, those that inhibit phospholipase A.sub.2. More particularly in this regard, the invention relates to uteroglobin or muteins, peptide analogs or mimetics of uteroglobin and lipocortins or muteins, peptide analogs, or mimetics of lipocortins that inhibit metastasis. Especially it relates to methods and compositions in which uteroglobins, particularly human uteroglobins, inhibit or prevent metastasis of cancer, particularly prostatic cancer.

REFERENCES:
patent: 5266562 (1993-11-01), Mukherjee et al.
patent: 5284827 (1994-02-01), Maione et al.
patent: 5359078 (1994-10-01), Kohn et al.
Medline 82053036, abstract of Snead, J of Biological Chemistry, 1981, 256(22), pp. 11911-11916.
Manyak et al., J. Urology 140:176-182 (1988).
Broers et al., Laboratory Investigation 66(3): 337-346 (1992).
Miyamoto et al., J. Urology 149: 1015-1019 (May 1993).
Jensen et al., Int. J. Cancer 58: 629-637 (1994).
Linnoila et al., A.J.C.P. 97(2): 223-243 (Feb. 1992).
Peri et al., J. Clinical Inv. 92: 2099-2109 (Nov. 1993).
Morgan et al., Annu. Rev. Biochem. 62: 191-217 (1993).
Tolstoshev, Annu. Rev. Pharmocol. Toxicol. 32: 573-96 (1993).
Hill, R.R., Chapter 11, Metastasis, pp. 178-195 in The Basic Science of Oncology, Tannock et al., Eds., McGraw-Hill, N.Y. (1992).
Aznavoorian et al., Cancer, 71: 1368-83 (1993).
Singh et al., BBA, 950: 329-337 (1988).
Miele et al., Endocrine Reviews, 8: 474-90 (1987).
Nieto et al., Arch. Biochem. Biophys., 180: 82-92 (1977).
Mantile et al., J. Biol. Chem., 268: 20343-20351 (1993).
Miele et al., J. Biol. Chem., 265: 6427-35 (1990).
Sambrook et al., Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. (1989).
Arcone et al., Eur. J. Biochem., 211: 347-55 (1993).
Cirino et al., British J. Pharmacol., 108:573-4 (1993).
Bastian et al., J. Invest. Dermatol., 101:359-63 (1993).
Monoclonal Antibodies--Production, Engineering and Clinical Applications, Ritter et al., Eds., Cambridge University Press, Cambridge, UK (1995).
Merk Index, 11th Ed., Budavari et al., Eds., Merk & Co., Inc. Rahway, N.J. (1989).
Goodman and Gilman's: The Pharmacological Bases of Therapeutics, 8th Ed., Gilman et al., Eds., Pergamon Press (1990).
Remington's Pharmaceutical Sciences, 17th Ed., Mack Publishing Co., Easton, PA (1990).
Cancer Therapy With Radiolabeled Antibodies, D.M. Goldenberg, Ed., CRC Press, Boca Raton, FL (1995).
Stone et al., Int. J. Cancer, 21: 274-281 (1978).
Horoszewicz et al., Cancer Res., 43: 1809-18 (1983).
Kaighn et al., Invent. Urol., 17: 16-23 (1979).
Hzumi et al., J. Urology, 137: 1304-1306 (1987).
Albini et al., Cancer Research, 47: 3239-3245 (1987).
Leyton et al., Cancer Research, 54: 3696-3699 (1994).
Frandson et al., Fibrinolysis, 6 (Supp. 4): 71-76 (1992).
Manyak et al., J. Urology, 151: 368A (1994).
Cerboon et al., J. steroid Biochem., 36: 1-6 (1990).
Lopez de Haro et al., FEBS Letters, 232: 351-353 (1988).
Aumuller et al., Histochemistry, 83: 413-417 (1985).
Tibes et al., Expert Opin. Invest. Drugs, 6: 279-298 (1997).
Dannhorn et al., J. Immunol. Meth., 119: 223-230 (1989).
Osband et al., Immunology Today, 11: 193-195 (1990).
Mayer et al., Expert Opin. Invest. Drugs, 5: 535-554 (1996).
Leyton et al., Proc. Amer. Assoc. Canc. Res. 35: 280 (1994).

Affiliated with

Also associated with

Rating

Kit for indentifying prostatic intraepithelial neoplasia (PIN) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Kit for indentifying prostatic intraepithelial neoplasia (PIN), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kit for indentifying prostatic intraepithelial neoplasia (PIN) will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-992597